Appointed
Yang Li
Chief Executive Officer
LSH ·
Lakeside Holding Ltd
Following Mr. Liu’s resignation, Mr. Yang Li serves as the sole Chief Executive Officer of the Company.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1201–1250 of 75328
Departed
Henry Liu
Co-Chief Executive Officer
LSH ·
Lakeside Holding Ltd
Henry Liu, who currently serves as one of the Company’s Co-Chief Executive Officers, provided notice to the Company of his resignation as Co-Chief Executive Officer, effective June 2, 2026.
Appointed
Timothy McHugh
Director
FVR ·
FrontView REIT, Inc.
On June 1, 2026, the Board approved an equity grant to Mr. McHugh with a grant date value substantially equivalent to that of the annual equity grants received by the Company’s continuing non-employee directors under the Non-Employee Director Compensation Policy on May 27, 2026, the date of our 2026 annual meeting of stockholders.
Departed
Eric Haynor
Chief Operating Officer
PRPL ·
Purple Innovation, Inc.
Eric Haynor, who currently serves as the Company’s Chief Operating Officer, provided notice to the Company of his resignation as Chief Operating Officer effective June 5, 2026.
Departed
Terence J. Voskuil
Executive Vice President, Chief Technology Officer, Aerospace
WWD ·
Woodward, Inc.
On June 2, 2026, Terence J. Voskuil notified Woodward, Inc. of his intention to retire from his position as Executive Vice President, Chief Technology Officer, Aerospace, effective October 2, 2026 (the
Departed
Theresa Greco
Chief Commercial Officer
OPRX ·
OptimizeRx Corp
Accordingly, effective as of the Separation Date, Ms. Greco will no longer serve as the Company’s Chief Commercial Officer.
Departed
Carrie D'Andrea
Vice President of Clinical Operations
GRCE ·
Grace Therapeutics, Inc.
Carrie D’Andrea will cease serving as Vice President of Clinical Operations of the Company and will no longer be employed by the Company effective June 5, 2026
Appointed
Thomas Lynch
Director
NTRA ·
Natera, Inc.
appointed Thomas Lynch as a member of the Board, in each case effective as of June 2, 2026.
Departed
Arnaud Weber
Engineering Lead
XYZ ·
Block, Inc.
the Company announced that Arnaud Weber, the Company’s Engineering Lead, departed the Company on June 5, 2026.
Appointed
John Salemi
Director
APMC ·
AmperCap Acquisition Co
On June 2, 2026, in connection with the IPO, John Salemi, Luis Pena Kegel, and Alfredo Flores Ibarrola (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Appointed
Luis Pena Kegel
Director
APMC ·
AmperCap Acquisition Co
On June 2, 2026, in connection with the IPO, John Salemi, Luis Pena Kegel, and Alfredo Flores Ibarrola (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Appointed
Alfredo Flores Ibarrola
Director
APMC ·
AmperCap Acquisition Co
On June 2, 2026, in connection with the IPO, John Salemi, Luis Pena Kegel, and Alfredo Flores Ibarrola (collectively, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).
Departed
Wilfred Daye
Director and Chief Strategy Officer
CD ·
Chaince Digital Holdings Inc.
On June 3, 2026, Wilfred Daye resigned as a member of the board of directors (the “Board”) of Chaince Digital Holdings Inc. (the “Company”) and as Chief Strategy Officer of the Company, effective immediately.
Departed
Mark A. Alexander
Director
BLDR ·
Builders FirstSource, Inc.
On June 3, 2026, Mark A. Alexander notified the Board of Directors (the "Board") of Builders FirstSource, Inc. (the "Company") of his resignation from the Board, effective immediately, due to health reasons.
Departed
John Christopher Shelton
director
FLNC ·
Fluence Energy, Inc.
On June 2, 2026, John Christopher ("Chris") Shelton notified the Board of Directors (the "Board") of Fluence Energy, Inc. (the "Company") of his resignation from the Board, effective as of the close of business on June 3, 2026.
Appointed
Bernerd Da Santos
director
FLNC ·
Fluence Energy, Inc.
On June 3, 2026, the Board appointed Mr. Bernerd Da Santos as a director, effective as of the close of business on June 3, 2026, for a term expiring at the Company’s annual meeting of stockholders to be held in 2027
Appointed
Marie Washburn
Chief Financial Officer
LGVN ·
Longeveron Inc.
who the Company anticipates will be elevated into the CFO role upon Ms. Locklear’s departure (pending final contract).
Departed
Lisa Locklear
Chief Financial Officer
LGVN ·
Longeveron Inc.
On June 1, 2026, Ms. Lisa Locklear informed management of Longeveron Inc. (the “Company”) of her decision to step down as Chief Financial Officer, to become effective July 10, 2026.
Departed
Alka Chaubey
Chief Medical Officer
BNGO ·
Bionano Genomics, Inc.
On June 2, 2026, Alka Chaubey, Ph.D. resigned as Chief Medical Officer of Bionano Genomics, Inc. (the “Company”) effective July 5, 2026.
Appointed
Victor Sandor
Director
ABCL ·
AbCellera Biologics Inc.
On June 1, 2026, the Board of Directors (the "Board") of AbCellera Biologics Inc. (the "Company") appointed Victor Sandor as a new director.
Departed
Reid Hoffman
Director
MSFT ·
MICROSOFT CORP
On June 2, 2026, Reid Hoffman, a member of the Board of Directors of Microsoft Corporation (the “Company”) since 2017, informed the Company of his decision not to stand for re-election at the Company’s 2026 annual shareholder meeting (the “Annual Meeting”).
Appointed
David Lissy
Director
UPWK ·
UPWORK, INC
the Board, at the recommendation of its nominating and governance committee, nominated each of Claire Bramley and David Lissy for election as a Class II director at the Annual Meeting.
Departed
Leela Srinivasan
Director
UPWK ·
UPWORK, INC
As previously disclosed, Leela Srinivasan did not stand for re-election as a member of the board of directors
Appointed
Claire Bramley
Director
UPWK ·
UPWORK, INC
the Board, at the recommendation of its nominating and governance committee, nominated each of Claire Bramley and David Lissy for election as a Class II director at the Annual Meeting.
Departed
Anilu Vazquez-Ubarri
Director
UPWK ·
UPWORK, INC
Anilu Vazquez-Ubarri resigned from the Board effective immediately prior to the election of directors at the Annual Meeting.
Appointed
Greg Deisher
Chief Operating Officer and Executive Vice President
VEEA ·
VEEA INC.
the Board appointed Greg Deisher , who is currently a Senior Vice President of the Company, to serve the Chief Operating Officer and Executive Vice President filling the vacancy created by the previous resignation of Ms. Janice K. Smith.
Appointed
Mark Tubinis
Executive Vice President
VEEA ·
VEEA INC.
the Board appointed Mark Tubinis , who is currently the Chief Commercial Officer of the Company, to also serve as an Executive Vice President.
Appointed
Michael E. Williamson
Class III Director
SATL ·
Satellogic Inc.
Effective June 1, 2026, the Board of Directors (the “Board”) of Satellogic Inc. (the “Company”) increased the size of the Board from seven directors to eight directors and appointed Michael E. Williamson to fill the vacancy as a Class III Director.
Appointed
John David Yee
Class II Director
TPST ·
Tempest Therapeutics, Inc.
the Board appointed Dr. John David Yee and Mr. William Drake Richey as Class II directors to fill vacancies on the Board.
Appointed
Justin Trojanowski
Vice President, Finance, Principal Financial Officer and Corporate Secretary
TPST ·
Tempest Therapeutics, Inc.
the Board of Directors of the Company (the “Board”) appointed Mr. Justin Trojanowski as Vice President, Finance, Principal Financial Officer and Corporate Secretary of the Company, in addition to his current role as Corporate Controller, Treasurer and Principal Accounting Officer of the Company.
Appointed
William Drake Richey
Class II Director
TPST ·
Tempest Therapeutics, Inc.
the Board appointed Dr. John David Yee and Mr. William Drake Richey as Class II directors to fill vacancies on the Board.
Departed
Nicholas Maestas
Chief Financial Officer
TPST ·
Tempest Therapeutics, Inc.
Mr. Nicholas Maestas notified Tempest Therapeutics, Inc. (the “Company”) of his decision to resign from his position as Chief Financial Officer of the Company and from any and all other positions he holds with the Company, effective as of June 5, 2026.
Appointed
Ohad Harlev
Independent Director
DRCT ·
Direct Digital Holdings, Inc.
On June 3, 2026, the Board of Directors (the “Board”) of Direct Digital Holdings, Inc. (the “Company”) appointed Ohad Harlev to serve as an Independent Director on its Board, effective immediately, and increased the size of its Board in connection with his appointment.
Appointed
(interim)
Johnathan Daniel
Chief Accounting Officer
BWIN ·
Baldwin Insurance Group, Inc.
On June 4, 2026, the Board of Directors of The Baldwin Insurance Group, Inc. (the “Company”) appointed Johnathan Daniel to serve as interim Chief Accounting Officer of the Company effective upon the commencement of Corbyn Lichon’s, the Company’s Chief Accounting Officer, maternity leave, which is expected to begin in mid-to-late June 2026.
Departed
Kevin Knight
Executive Chairman
KNX ·
Knight-Swift Transportation Holdings Inc.
On June 3, 2026, Mr. Kevin Knight resigned as Executive Chairman of the Board of Directors (the “Board”) and member of the Board of Knight-Swift Transportation Holdings Inc. (the “Company”), effective June 3, 2026 (the “Effective Date”).
Appointed
David Vander Ploeg
Chair of the Board
KNX ·
Knight-Swift Transportation Holdings Inc.
The Board appointed David Vander Ploeg as Chair of the Board effective upon Mr. Knight’s resignation.
Departed
Yilin Lu
President
YHC ·
LQR House Inc.
On June 4, 2026, Yilin Lu resigned from his position as the President and a member of the Board of Directors of LQR House Inc. (the “ Company ”), effective immediately.
Appointed
Angela Krezmer
Executive Vice President and Chief Financial Officer
SNNF ·
Seneca Bancorp, Inc.
On May 29, 2026, the Company and the Bank appointed Angela Krezmer (age 40) to succeed Mr. Fazio as Executive Vice President and Chief Financial Officer effective July 1, 2026.
Appointed
Angelo Testani
Executive Vice President and Chief Banking Officer
SNNF ·
Seneca Bancorp, Inc.
In addition, on May 29, 2026, the Company and the Bank appointed Angelo Testani to the position of Executive Vice President and Chief Banking Officer.
Departed
Vincent Fazio
Executive Vice President and Chief Financial Officer
SNNF ·
Seneca Bancorp, Inc.
On May 29, 2026, Vincent Fazio notified Seneca Bancorp, Inc. (the “Company”) and its bank subsidiary, Seneca Savings Bank, National Association (the “Bank”), that he intends to retire as the Company’s and the Bank’s Executive Vice President and Chief Financial Officer effective at the close of business on June 30, 2026.
Departed
Michael L. Perkins
Senior Executive Vice President and Chief Risk Officer
WSBC ·
WESBANCO INC
Michael L. Perkins informed the Board of Directors of Wesbanco, Inc. (the “Company”) that Mr. Perkins will retire from his position as the Company’s Senior Executive Vice President and Chief Risk Officer, effective June 30, 2026.
Appointed
Shelley Bausch
Class II director
IOSP ·
INNOSPEC INC.
appointed Shelley Bausch to serve as a Class II director of the Company starting as of July 1, 2026
Appointed
Luisa Ingargiola
Chief Strategy Officer
ALBT ·
Avalon GloboCare Corp.
On June 3, 2026, the board of directors of Avalon GloboCare Corp. (the “Company”) appointed Luisa Ingargiola as the Company’s Chief Strategy Officer, and Sam Knipper as the Company’s Chief Financial Officer, in each case, effective June 3, 2026 (the “Effective Date”).
Appointed
Sam Knipper
Chief Financial Officer
ALBT ·
Avalon GloboCare Corp.
On June 3, 2026, the board of directors of Avalon GloboCare Corp. (the “Company”) appointed Luisa Ingargiola as the Company’s Chief Strategy Officer, and Sam Knipper as the Company’s Chief Financial Officer, in each case, effective June 3, 2026 (the “Effective Date”).
Departed
Kathryn Gregory
Director
XAGE ·
Longevity Health Holdings, Inc.
On June 1, 2026, Kathryn Gregory notified Longevity Health Holdings, Inc. (the “Company”) of her resignation from the Board of Directors of the Company, effective as of the close of business on June 1, 2026.
Appointed
Cheryl Ash
Senior Vice President, Finance and North America, as well as the Chief Financial Officer of Bally’s Chicago
Bally's Chicago, Inc.
On May 29, 2026, Bally’s Management Group, LLC, a subsidiary of Bally’s Corporation, entered into an employment agreement with Cheryl Ash, as its Senior Vice President, Finance and North America, as well as the Chief Financial Officer of Bally’s Chicago.
Departed
Jay Geldmacher
Director
REZI ·
RESIDEO TECHNOLOGIES, INC.
Mr. Surran will succeed Jay Geldmacher, who will transition to an executive advisor role and will resign from the Board following the appointment of Mr. Surran upon consummation of the ADI Spin-Off Transaction, pursuant to the terms of a previously announced transition arrangement.
Appointed
Thomas Surran
President and Chief Executive Officer
REZI ·
RESIDEO TECHNOLOGIES, INC.
the Board of Directors (the “Board”) of the Company approved the appointment of Thomas Surran as President and Chief Executive Officer of the Company and as a director of the Company, in each case effective upon consummation of the ADI Spin-Off Transaction (the “Separation Date”).
Appointed
Thomas Surran
Director
REZI ·
RESIDEO TECHNOLOGIES, INC.
the Board of Directors (the “Board”) of the Company approved the appointment of Thomas Surran as President and Chief Executive Officer of the Company and as a director of the Company, in each case effective upon consummation of the ADI Spin-Off Transaction (the “Separation Date”).
Departed
Jay Geldmacher
Chief Executive Officer
REZI ·
RESIDEO TECHNOLOGIES, INC.
Mr. Surran will succeed Jay Geldmacher, who will transition to an executive advisor role and will resign from the Board following the appointment of Mr. Surran upon consummation of the ADI Spin-Off Transaction, pursuant to the terms of a previously announced transition arrangement.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.